# A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects

> **NCT04778072** · NA · UNKNOWN · sponsor: **Solvotrin Innovations Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Premenopause
- Iron-deficiency
- Iron Adverse Reaction
- Iron Deficiency Anemia
- Heavy Menstrual Bleeding

## Interventions

- **DIETARY_SUPPLEMENT:** Ferrous sulfate 14mg once daily
- **DIETARY_SUPPLEMENT:** Ferrous sulfate 25mg once daily
- **DIETARY_SUPPLEMENT:** Ferrous sulfate 25mg twice daily

## Key facts

- **NCT ID:** NCT04778072
- **Lead sponsor:** Solvotrin Innovations Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-08
- **Primary completion:** 2021-04-09
- **Final completion:** 2021-05-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04778072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04778072, "A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04778072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*